Organization Overview
Alternative names
adalimumab (humira) (2023)
bevacizumab (avastin) (2022)
clobazam (onfi) (2020)
clopidogrel (plavix) (2012)
deferasirox (exjade) (2021)
droxidopa (northera) (2022)
famotidine (pepcid) (2001)
fluoxetine (prozac) (2008)
infliximab (remicade) (2016)
lamivudine (epivir) (2018)
lamotrigine (lamictal) (2009)
levofloxacin (levaquin) (2011)
linezolid (zyvox) (2019)
memantine (namenda) (2015)
pioglitazone (actos) (2012)
pregabalin (lyrica) (2020)
risperidone (risperdal) (2008)
rituximab (rituxan) (2018)
rizatriptan (maxalt) (2013)
ropinirole (Requip) (2008)
sodium chloride (2011)
solifenacin (vesicare) (2019)
telmisartan (micardis) (2014)
tenofovir (viread) (2018)
trastuzumab (herceptin) (2018)
valproic acid (depakene) (2008)
zonisamide (Zonegran) (2005)
Adenocarcinoma (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Breast Neoplasms (Phase 3)
Cardiomyopathies (Phase 1)
Cardiomyopathy, Hypertrophic (Phase 1)
Colitis (Phase 4)
Colitis, Ulcerative (Phase 4)
Coronavirus Infections (Phase 3)
Crohn Disease (Phase 3)
Hypertrophy (Phase 1)
Infections (Phase 3)
Influenza, Human (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 1)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 1)
Psoriasis (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Spondylitis (Phase 1)
Spondylitis, Ankylosing (Phase 1)
Stomach Neoplasms (Phase 2)
Ulcer (Phase 4)
Urticaria (Phase 3)